BROADLY NEUTRALIZING ANTIBODIES FROM AN INDIVIDUAL THAT NATURALLY CLEARED MULTIPLE HEPATITIS C VIRUS INFECTIONS UNCOVER MOLECULAR DETERMINANTS FOR E2 TARGETING AND VACCINE DESIGN.

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.

Cumulative evidence supports a role for neutralizing antibodies contributing to spontaneous viral clearance during acute hepatitis C virus (HCV) infection.Information on the timing and specificity of the B cell response associated with clearance is crucial to inform vaccine design.From an individual who cleared three sequential HCV infections with

read more